Table 2.
Baseline demographic and clinical characteristics by group
| Measure | All (n = 41) | CBIT (n = 25) | WL (n = 16) | Statistic | P |
|---|---|---|---|---|---|
| Age, mean (SD) | 11.26 (1.94) | 11.42 (2.19) | 11.01 (1.49) | t(39) = 0.66 | 0.51 |
| Gender, mean (SD) | |||||
| Males | 29 (70.73%) | 17 (68%) | 12 (75%) | χ2 = 0.23 | 0.63 |
| Females | 12 (29.26%) | 8 (32%) | 4 (25%) | ||
| Maternal age, mean (SD) | 41.24 (4.02) | 42.04 (3.92) | 40 (3.98) | t(39) = 1.60 | 0.11 |
| Maternal years of education, mean (SD) | 16.21 (2.57) | 16.36 (2.3) | 16 (3.01) | t(39) = 0.43 | 0.66 |
| Maternal employment status, n (%) | |||||
| Full-time job | 22 (53.65%) | 14 (56.00%) | 8 (50.00%) | χ2(2) = 1.53 | 0.46 |
| Part-time job | 14 (34.14%) | 7 (28.00%) | 7 (43.75%) | ||
| Unemployed | 5 (12.19) | 4 (16.00%) | 1 (6.25%) | ||
| Paternal age, mean (SD) | 43.06 (3.88) | 43.41 (3.58) | 42.53 (4.37) | t(36) = 0.67 | 0.50 |
| Paternal years of education, mean (SD) | 15.4 (2.7) | 15.82 (2.82) | 14.86 (2.5) | t(36) = 1.06 | 0.29 |
| Paternal employment status, n (%) | |||||
| Full-time job | 33 (80.48%) | 20 (80.00%) | 13 (81.25%) | χ2(2) = 0.14 | 0.93 |
| Part-time job | 3 (7.31%) | 2 (8.00%) | 1 (6.25%) | ||
| Unemployed | 2 (4.87%) | 1 (4.00%) | 1 (6.25%) | ||
| Current medication use, n (%) | |||||
| No | 31 (75.60%) | 21 (84%) | 10 (62.5%) | χ2(1) = 1.52 | 0.21 |
| α-agonists | 4 (9.75%) | 1 (4%) | 3 (18.75%) | ||
| Antipsychotics | 1 (2.43%) | 1 (4%) | – | ||
| SSRI (Anxiety) | 1 (2.43%) | – | 1 (6.25%) | ||
| Benzodiazepine | 1 (2.43%) | 1 (4%) | |||
| Stimulants (ADHD) | 2 (4.87%) | 1 (4%) | 1 (6.25%) | ||
| Medicinal-herbs | 1 (2.6%) | – | 1 (6.25%) | ||
| Past psychotherapy experience, n (%) | |||||
| No | 13 (31.7%) | 8 (32%) | 5 (31.25%) | χ2(5) = 2.44 | 0.78 |
| Psychotherapy | 12 (29.26%) | 7 (28%) | 5 (31.25%) | ||
| Expressive Arts Therapy | 7 (17.07%) | 4 (16%) | 3 (18.75%) | ||
| Occupational therapy | 5 (12.19%) | 4 (16%) | 1 (6.25%) | ||
| Animal-assisted therapy | 1 (2.43%) | – | 1 (6.25%) | ||
| Acupuncture | 3 (7.31%) | 2 (8%) | 1 (6.25%) | ||
| Tic disorder, n (%) | |||||
| CTD | 9 (21.95%) | 6 (24%) | 3 (18.75%) | t(7) = 1.33 | 0.21 |
| TS | 31 (75.6%) | 19 (76%) | 13 (81.25%) | t(30) = 0.87 | 0.50 |
| SAD, n (%) | 6 (14.63%) | 3 (12%) | 3 (18.75%) | χ2(1) = 0.35 | 0.55 |
| GAD, n (%) | 16 (39.02%) | 11 (44%) | 5(31.25%) | χ2(1) = 066 | 0.41 |
| SPD, n (%) | 9 (21.95%) | 6 (24%) | 3 (18.75%) | χ2(1) = 0.15 | 0.69 |
| SP, n (%) | 4 (9.80%) | 4 (16%) | – | χ2(1) = 2.83 | 0.04 |
| OCD, n (%) | 13 (31.70%) | 6 (26.08%) | 7 (43.75%) | χ2(1) = 2.41 | 0.29 |
| Dysthymia, n (%) | 3 (7.31%) | 3 (12%) | – | χ2(1) = 2.07 | 0.15 |
| Enuresis, n (%) | 3 (7.31%) | 2 (8%) | 1 (6.25%) | χ2(1) = 0.44 | 0.83 |
| Encopresis, n (%) | 1 (2.43%) | 1 (4%) | – | χ2(1) = 0.65 | 0.41 |
| ADHD, n (%) | 18 (43.90%) | 10 (39.13%) | 8 (46.66%) | χ2(1) = 3.96 | 0.52 |
| LD, n (%) | 7 (17.07%) | 4 (16%) | 3 (18.75%) | χ2(1) = 0.052 | 0.81 |
| SMD, n (%) | 6 (14.63%) | 4 (16%) | 2 (12.5%) | χ2(1) = 0.09 | 0.75 |
SAD separation anxiety disorder, SPD social phobia disorder, GAD general anxiety disorder; SP specific phobia, OCD obsessive–compulsive disorder and subclinical OCD, ADHD attention-deficit hyperactivity disorder, LD learning disabilities, SMD sensory modulation disorder